Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:1278-1284
Published online before print April 9, 2007, doi: 10.1161/HYPERTENSIONAHA.107.086942
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/6/1278    most recent
HYPERTENSIONAHA.107.086942v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raggi, P.
Right arrow Articles by Muntner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raggi, P.
Right arrow Articles by Muntner, P.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Imaging
Right arrow CT and MRI
Right arrow Other diagnostic testing
Right arrow Chronic ischemic heart disease

(Hypertension. 2007;49:1278.)
© 2007 American Heart Association, Inc.


Original Articles

Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients

Paolo Raggi; Antonio Bellasi; Emiliana Ferramosca; Geoffrey A. Block; Paul Muntner

From the Division of Cardiology and Departments of Medicine and Radiology (P.R., A.B.), Emory University School of Medicine, Atlanta, Ga; the Department of Nephrology (A.B.), Ospedale San Paolo and University of Milan, Milan, Italy; the Department of Nephrology (E.F.), Ospedale Malpighi and University of Bologna, Bologna, Italy; Denver Nephrology (G.A.B.), professional corporation, Denver, Colo; and the Department of Epidemiology (P.M.), Tulane University, New Orleans, La.

Correspondence to Paolo Raggi, Emory University School of Medicine, 1365 Clifton Rd NE, AT-504, Atlanta, GA 30322; E-mail praggi{at}emory.edu

Abnormalities of bone mineral metabolism in patients with stage-5 chronic kidney disease may contribute to the high incidence of cardiovascular disease. Noninvasive imaging methods may help predict the simultaneous presence of vasculopathy and bone disease. Accordingly, we measured pulse wave velocity and bone mineral density (BMD), and T-scores (number of SDs below the BMD of a younger reference group) of the spine by both dual energy x-ray absorptiometry and quantitative computed tomography (QCT) in 110 maintenance hemodialysis patients. Older age, white race, diabetes mellitus, lower diastolic blood pressure, and lower albumin levels were associated with lower QCT-assessed T-scores (each P<0.05). After age and multivariable adjustment, pulse wave velocity (PWV) increased as QCT BMD decreased (the prevalence of PWV ≥9 m/s was 32.4%, 61.8%, and 76.5% for participants in the highest to the lowest tertile of QCT-assessed BMD; P<0.001). In contrast, there was no relationship between spine dual energy x-ray absorptiometry-BMD and PWV. In unadjusted models, thoracic spine QCT-assessed T-scores correlated significantly, albeit weakly, with aorta calcification (r=0.22; P=0.01) but not with coronary calcification. The odds ratio of PWV ≥9 m/s for patients taking vitamin D3 or its analogs was 0.51 (95% CI: 0.19 to 1.39). In conclusion, low spine BMD is associated with increased PWV in stage-5 chronic kidney disease, supporting the notion of a close interaction of vascular and bone disease in this patient group. QCT and not dual energy x-ray absorptiometry should be used to assess spine BMD in dialysis patients.


Key Words: computed tomography • pulse wave velocity • bone density • vascular calcification • calcium • vascular stiffness




This article has been cited by other articles:


Home page
CJASNHome page
G. M. London
Bone-Vascular Axis in Chronic Kidney Disease: A Reality?
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 254 - 257.
[Full Text] [PDF]


Home page
CJASNHome page
N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr
Determination and Validation of Aortic Calcification Measurement from Lateral Bone Densitometry in Dialysis Patients
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. D. Toussaint, G. J. Elder, and P. G. Kerr
Bisphosphonates in Chronic Kidney Disease; Balancing Potential Benefits and Adverse Effects on Bone and Soft Tissue
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. M. London, S. J. Marchais, A. P. Guerin, P. Boutouyrie, F. Metivier, and M.-C. de Vernejoul
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1827 - 1835.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Raggi and M. Kleerekoper
Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy
Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. S. DeLoach and R. R. Townsend
Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 184 - 192.
[Abstract] [Full Text] [PDF]